The use of contrast‐enhanced transthoracic echocardiography for spiral‐variant hypertrophic cardiomyopathy
暂无分享,去创建一个
[1] R. Biederman,et al. The Use of Contrast-Enhanced Transthoracic Echocardiography for Spiral Variant Hypertrophic Cardiomyopathy , 2020 .
[2] B. Popescu,et al. The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy , 2020, Journal of Echocardiography.
[3] Jong-Min Song,et al. Geometric predictors of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a 3D computed tomography analysis , 2018, European heart journal cardiovascular Imaging.
[4] B. Gersh,et al. Hypertrophic Cardiomyopathy: Clinical Update. , 2018, JACC. Heart failure.
[5] W. Vletter,et al. Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy , 2018, Journal of Ultrasound.
[6] F. Alfonso,et al. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications , 2017, The International Journal of Cardiovascular Imaging.
[7] N. Smedira,et al. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. , 2015, Circulation. Cardiovascular imaging.
[8] Nessim N. Amin,et al. Spiral Hypertrophic Cardiomyopathy as Detected by Cardiac Magnetic Resonance , 2014, Echocardiography.
[9] P. Claus,et al. Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR. , 2012, JACC. Cardiovascular imaging.
[10] N. Reichek. Seeing spirals. , 2012, JACC. Cardiovascular imaging.
[11] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[12] Vasken Dilsizian,et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[13] Jeroen J. Bax,et al. Value of contrast echocardiography for left ventricular thrombus detection postinfarction and impact on antithrombotic therapy , 2009, Coronary artery disease.
[14] W. Manning,et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.
[15] Mustafa Kurt,et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. , 2009, Journal of the American College of Cardiology.
[16] N. Reichek,et al. Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm. , 2008, Journal of the American College of Cardiology.
[17] J. Bogaert,et al. Helical form of hypertrophic cardiomyopathy: a new entity? , 2008, European heart journal.
[18] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.
[19] N. Nanda,et al. Imagent Improves Endocardial Border Delineation, Inter‐reader Agreement, and the Accuracy of Segmental Wall Motion Assessment , 2003, Echocardiography.
[20] B. Maron,et al. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.
[21] C. Higgins,et al. Magnetic resonance imaging in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.
[22] Barry J Maron,et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.